Harvard Women's Health Watch

Experts add second drug to breast cancer prevention regimen

New guidelines advise postmenopausal women at increased risk for estrogen receptor-positive breast cancer to talk to their doctor about taking exemestane (Aromasin) as part of a preventive strategy.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »